ABVC BioPharma, Inc. (ABVC)
NASDAQ: ABVC · Real-Time Price · USD
2.190
+0.060 (2.82%)
At close: Jan 2, 2026, 4:00 PM EST
2.200
+0.010 (0.46%)
After-hours: Jan 2, 2026, 6:25 PM EST
ABVC BioPharma Market Cap
ABVC BioPharma has a market cap or net worth of $51.62 million as of January 2, 2026. Its market cap has increased by 682.11% in one year.
Market Cap
51.62M
Enterprise Value
53.83M
1-Year Change
682.11%
Ranking
Category
Stock Price
$2.19
Market Cap Chart
Since August 3, 2021, ABVC BioPharma's market cap has decreased from $79.50M to $51.62M, a decrease of -35.07%. That is a compound annual growth rate of -9.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 2, 2026 | 53.20M | 2.70% |
| Dec 31, 2025 | 51.80M | 572.73% |
| Dec 31, 2024 | 7.70M | -8.33% |
| Dec 29, 2023 | 8.40M | -58.82% |
| Dec 30, 2022 | 20.40M | -78.97% |
| Dec 31, 2021 | 97.00M | 22.01% |
| Aug 3, 2021 | 79.50M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.33B |
| Johnson & Johnson | 499.57B |
| AbbVie | 405.28B |
| UnitedHealth Group | 304.72B |
| AstraZeneca | 284.35B |
| Novartis AG | 266.00B |
| Merck & Co. | 264.21B |
| Novo Nordisk | 230.76B |